LNWWM
ANRO icon

Laird Norton Wetherby Wealth Management’s Alto Neuroscience ANRO Stock Holding History

Laird Norton Wetherby Wealth Management’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$338K Hold
84,162
– – 0.01% 711
2025
Q2 		$185K Buy
+84,162
New +$200K 0.01% 892
2024
Q4 		$356K Hold
84,162
– – 0.02% 647
2024
Q3 		$963K Buy
+84,162
New +$1.03M 0.04% 372

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Laird Norton Wetherby Wealth Management's ANRO Position: Q3 2025 in Review

Laird Norton Wetherby Wealth Management held its Alto Neuroscience (ANRO) position steady in Q3 2025 at 84,162 shares worth $338K. The position accounts for 0.01% of the portfolio, ranked #711.

Laird Norton Wetherby Wealth Management first reported a position in ANRO in Q3 2024 and has held it in 4 quarters since. The position peaked at $963K in Q3 2024. 77 funds tracked by Wall St. Rank hold ANRO as of Q3 2025.

  • Laird Norton Wetherby Wealth Management held 84,162 shares of Alto Neuroscience worth $338K as of Q3 2025.
  • Laird Norton Wetherby Wealth Management left its Alto Neuroscience share count unchanged in Q3 2025.
  • Alto Neuroscience made up 0.01% of Laird Norton Wetherby Wealth Management's portfolio in Q3 2025, its #711 holding.
  • Laird Norton Wetherby Wealth Management first reported a position in Alto Neuroscience in Q3 2024 and has held it in 4 quarters since.
  • Laird Norton Wetherby Wealth Management's Alto Neuroscience position peaked at $963K in Q3 2024.
  • 77 funds tracked by Wall St. Rank held Alto Neuroscience as of Q3 2025.

Based on Laird Norton Wetherby Wealth Management's 13F filing for Q3 2025, filed 14 Nov 2025.